{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T05:24:39Z","timestamp":1772774679560,"version":"3.50.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T00:00:00Z","timestamp":1573689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s00436-019-06493-6","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T06:03:11Z","timestamp":1573711391000},"page":"3479-3489","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of an in vitro system to study the developmental stages of Toxoplasma gondii using a genetically modified strain expressing markers for tachyzoites and bradyzoites"],"prefix":"10.1007","volume":"118","author":[{"given":"J.A.","family":"Portes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1895-1299","authenticated-orcid":false,"given":"W.","family":"De Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,14]]},"reference":[{"issue":"1","key":"6493_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/cbdd.13070","volume":"91","author":"DA Abugri","year":"2017","unstructured":"Abugri DA, Witola WH, Russell AE, Troy RM (2017) In vitro activity of the interaction between taxifolin (dihydroquercetin) and pyrimethamine against Toxoplasma gondii. Chem Biol Drug Des 91(1):194\u2013201. https:\/\/doi.org\/10.1111\/cbdd.13070","journal-title":"Chem Biol Drug Des"},{"key":"6493_CR2","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1002\/cyto.a.21138","volume":"79","author":"D Aldebert","year":"2011","unstructured":"Aldebert D, Hypolite M, Cavailles P, Touquet B, Flori P, Loeuillet C, Cesbron-Delauw MF (2011) Development of high throughput methods to quantify cysts of Toxoplasma gondii. Cytometry A 79:952\u2013958. https:\/\/doi.org\/10.1002\/cyto.a.21138","journal-title":"Cytometry A"},{"issue":"2","key":"6493_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/AAC.36.2.326","volume":"36","author":"FG Araujo","year":"1992","unstructured":"Araujo FG, Huskinson-Mark J, Gutteridge WE, Remington JS (1992) In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii. Antimicrob Agents Chemother 36(2):326\u2013330. https:\/\/doi.org\/10.1128\/AAC.36.2.326","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"6493_CR4","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1128\/IAI.62.5.1761-1767.1994","volume":"62","author":"W Bohne","year":"1994","unstructured":"Bohne W, Heesemann J, Gross U (1994) Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion. Infect Immun 62(5):1761\u20131767","journal-title":"Infect Immun"},{"key":"6493_CR5","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S1369-5274(02)00349-1","volume":"5","author":"JC Boothroyd","year":"2002","unstructured":"Boothroyd JC, Grigg ME (2002) Population biology of Toxoplasma gondii and its relevance to human infection: do different strains cause different disease? Curr Opin Microbiol 5:438\u2013442. https:\/\/doi.org\/10.1016\/S1369-5274(02)00349-1","journal-title":"Curr Opin Microbiol"},{"key":"6493_CR6","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1017\/S0950268813001507","volume":"142","author":"EV Carellos","year":"2014","unstructured":"Carellos EV, Caiaffa WT, Andrade GM, Abreu MN, Janu\u00e1rio JN (2014) Congenital toxoplasmosis in the state of Minas Gerais, Brazil: a neglected infectious disease? Epidemiol Infect 142:644\u2013655. https:\/\/doi.org\/10.1017\/S0950268813001507","journal-title":"Epidemiol Infect"},{"key":"6493_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3201\/eid1504.081306","volume":"15","author":"B Carme","year":"2009","unstructured":"Carme B, Demar M, Ajzenberg D, Dard\u00e9 ML (2009) Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis 15:656\u2013658. https:\/\/doi.org\/10.3201\/eid1504.081306","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"6493_CR8","doi-asserted-by":"publisher","first-page":"22997","DOI":"10.1038\/srep22997","volume":"15","author":"RA Charvat","year":"2016","unstructured":"Charvat RA, Arrizabalaga G (2016) Oxidative stress generated during monensin treatment contributes to altered Toxoplasma gondii mitochondrial function. Sci Rep Mar 15(6):22997. https:\/\/doi.org\/10.1038\/srep22997","journal-title":"Sci Rep Mar"},{"issue":"9","key":"6493_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1086\/339551","volume":"34","author":"K Chirgwin","year":"2002","unstructured":"Chirgwin K, Hafner R, Leport C, Remington J, Andersen J, Bosler EM, Roque C, Rajicic N, McAuliffe V, Morlat P, Jayaweera DT, Vilde JL, Luft BJ (2002) Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237\/ANRS 039 Study. AIDS Clinical Trials Group 237\/Agence Nationale de Recherche sur le SIDA, Essai 039. Clin Infect Dis 34(9):1243\u20131250. https:\/\/doi.org\/10.1086\/339551","journal-title":"Clin Infect Dis"},{"key":"6493_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ceb.2016.03.007","volume":"41","author":"MJ Coffey","year":"2016","unstructured":"Coffey MJ, Jennison C, Tonkin CJ, Boddey JA (2016) Role of the ER and Golgi in protein export by Apicomplexa. Curr Opin Cell Biol 41:18\u201324. https:\/\/doi.org\/10.1016\/j.ceb.2016.03.007","journal-title":"Curr Opin Cell Biol"},{"key":"6493_CR11","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.parint.2015.08.010","volume":"64","author":"LLR Da Silva","year":"2015","unstructured":"Da Silva LLR, Portes JA, De Ara\u00fajo MH, Silva JLS, Renn\u00f3 MN, Netto CD, Da Silva AJM, Costa PRR, De Souza W, Seabra SH, DaMatta RA (2015) Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro. Parasitol Int 64:622\u2013631","journal-title":"Parasitol Int"},{"key":"6493_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1051\/parasite\/2008153366","volume":"15","author":"ML Dard\u00e9","year":"2008","unstructured":"Dard\u00e9 ML (2008) Toxoplasma gondii, \u201cnew\u201d genotypes and virulence. Parasite 15:366\u2013371. https:\/\/doi.org\/10.1051\/parasite\/2008153366","journal-title":"Parasite"},{"key":"6493_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.3201\/eid1202.041115","volume":"12","author":"L De Moura","year":"2006","unstructured":"De Moura L, Bahia-Oliveira LM, Wada MY, Jones JL, Tuboi SH, Carmo EH, Ramalho WM, Camargo NJ, Trevisan R, Gra\u00e7a RM, Da Silva AJ, Moura I, Dubey JP, Garrett DO (2006) Waterborne toxoplasmosis, Brazil, from field to gene. Emerg Infect Dis 12:326\u2013329. https:\/\/doi.org\/10.3201\/eid1202.041115","journal-title":"Emerg Infect Dis"},{"key":"6493_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1128\/CMR.11.4.569","volume":"11","author":"EY Denkers","year":"1998","unstructured":"Denkers EY, Gazzinelli RT (1998) Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11:569\u2013588. https:\/\/doi.org\/10.1128\/CMR.11.4.569","journal-title":"Clin Microbiol Rev"},{"key":"6493_CR15","doi-asserted-by":"publisher","unstructured":"Di Genova BM, Wilson SK, Dubey JP, Knoll LJ (2019) Intestinal delta-6-desaturase activity determines host range for Toxoplasma sexual reproduction. BioRxiv 688580. https:\/\/doi.org\/10.1101\/688580","DOI":"10.1101\/688580"},{"issue":"6","key":"6493_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jac\/dkf251","volume":"50","author":"O Djurkovi\u0107-Djakovi\u0107","year":"2002","unstructured":"Djurkovi\u0107-Djakovi\u0107 O, Milenkovi\u0107 V, Nikoli\u0107 A, Bobi\u0107 B, Gruji\u0107 J (2002) Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii. J Antimicrob Chemother 50(6):981\u2013987. https:\/\/doi.org\/10.1093\/jac\/dkf251","journal-title":"J Antimicrob Chemother"},{"key":"6493_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.micinf.2004.09.016","volume":"7","author":"O Djurkovic-Djakovic","year":"2005","unstructured":"Djurkovic-Djakovic O, Nikolic A, Bobic B, Klun I, Aleksic A (2005) Stage conversion of Toxoplasma gondii RH parasites in mice by treatment with atovaquone and pyrrolidine dithiocarbamate. Microbes Infect 7:49\u201354. https:\/\/doi.org\/10.1016\/j.micinf.2004.09.016","journal-title":"Microbes Infect"},{"issue":"39","key":"6493_CR18","doi-asserted-by":"publisher","first-page":"15936","DOI":"10.1073\/pnas.1208069109","volume":"109","author":"JS Doggett","year":"2012","unstructured":"Doggett JS, Nilsen A, Forquer I, Wegmann KW, Jones-Brando L, Yolken RH, Bord\u00f3n C, Charman SA, Katneni K, Schultz T, Burrows JN, Hinrichs DJ, Meunier B, Carruthers VB, Riscoe MK (2012) Endochin-like quinolones are highly efficacious against acute and latent experimental toxoplasmosis. Proc Natl Acad Sci U S A 109(39):15936\u201315941. https:\/\/doi.org\/10.1073\/pnas.1208069109","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6493_CR19","doi-asserted-by":"publisher","unstructured":"Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG (2018) Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev 31(4). https:\/\/doi.org\/10.1128\/cmr.00057-17","DOI":"10.1128\/cmr.00057-17"},{"key":"6493_CR20","volume-title":"Toxoplasma gondii\u2014the model apicomplexan: perspectives and methods","author":"F Dzierszinski","year":"2007","unstructured":"Dzierszinski F, Knoll LJ (2007) Biology of bradyzoites 303\u2013320. In: Weiss LM, Kim K (eds) Toxoplasma gondii\u2014the model apicomplexan: perspectives and methods. Academic Press, London"},{"issue":"1","key":"6493_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijpara.2005.08.014","volume":"36","author":"Michael S. Eaton","year":"2006","unstructured":"Eaton MS, Weiss LM, Kim K (2006) Cyclic nucleotide kinases and tachyzoite\u2013bradyzoite transition in Toxoplasma gondii. Int J Parasitol 36(1):107-114. https:\/\/doi.org\/10.1016\/j.ijpara.2005.08.014","journal-title":"International Journal for Parasitology"},{"issue":"4","key":"6493_CR22","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s11011-016-9822-1","volume":"1","author":"HM Elsheikha","year":"2016","unstructured":"Elsheikha HM, B\u00fcsselberg D, Zhu XQ (2016) The known and missing links between Toxoplasma gondii and schizophrenia. Metab Brain Dis 1(4):749\u2013759. https:\/\/doi.org\/10.1007\/s11011-016-9822-1","journal-title":"Metab Brain Dis"},{"key":"6493_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/BF00930955","volume":"75","author":"DJP Fergurson","year":"1989","unstructured":"Fergurson DJP, Hutchison WM, Pettersen E (1989) Tissue cyst rupture in mice chronically infected with Toxoplasma gondii. An immunocytochemical and ultrastructural study. Parasitol Res 75:599\u2013603. https:\/\/doi.org\/10.1007\/BF00930955","journal-title":"Parasitol Res"},{"issue":"8","key":"6493_CR24","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1039\/b800520f","volume":"4","author":"MF Ferreira-da-Silva","year":"2008","unstructured":"Ferreira-da-Silva MF, Barbosa HS, Gross U, L\u00fcder CG (2008) Stress-related and spontaneous stage differentiation of Toxoplasma gondii. Mol BioSyst 4(8):824\u2013834. https:\/\/doi.org\/10.1039\/b800520f","journal-title":"Mol BioSyst"},{"key":"6493_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ijmm.2008.10.002","volume":"299","author":"MF Ferreira-da-Silva","year":"2009","unstructured":"Ferreira-da-Silva MF, Takacs AC, Barbosa HS, Gross U, Luder CG (2009a) Primary skeletal muscle cells trigger spontaneous Toxoplasma gondii tachyzoite to bradyzoite conversion at higher rates than fibroblasts. Int J Med Microbiol 299:381\u2013388. https:\/\/doi.org\/10.1016\/j.ijmm.2008.10.002","journal-title":"Int J Med Microbiol"},{"key":"6493_CR26","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1590\/S0074-02762009000200012","volume":"104","author":"MF Ferreira-da-Silva","year":"2009","unstructured":"Ferreira-da-Silva MF, Rodrigues RM, Andrade EF, Carvalho L, Gross U, Luder CG, Barbosa HS (2009b) Spontaneous stage differentiation of mouse virulent Toxoplasma gondii RH parasites in skeletal muscle cells: an ultrastructural evaluation. Mem Inst Oswaldo Cruz 104:196\u2013200. https:\/\/doi.org\/10.1590\/S0074-02762009000200012","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"6493_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ijpara.2003.12.001","volume":"34","author":"BA Fox","year":"2004","unstructured":"Fox BA, Gigley JP, Bzik DJ (2004) Toxoplasma gondii lacks the enzymes required for de novo arginine biosynthesis and arginine starvation triggers cyst formation. Int J Parasitol 34:323\u2013331. https:\/\/doi.org\/10.1016\/j.ijpara.2003.12.001","journal-title":"Int J Parasitol"},{"key":"6493_CR28","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13630-016-0025-5","volume":"5","author":"ME Francia","year":"2016","unstructured":"Francia ME, Dubremetz JF, Morrissette NS (2016) Basal body structure and composition in the apicomplexans Toxoplasma and Plasmodium. Cilia 5:3\u20137. https:\/\/doi.org\/10.1186\/s13630-016-0025-5","journal-title":"Cilia"},{"issue":"6","key":"6493_CR29","doi-asserted-by":"publisher","first-page":"e1671","DOI":"10.1371\/journal.pntd.0001671","volume":"6","author":"LH Freitas-Junior","year":"2012","unstructured":"Freitas-Junior LH, Siqueira-Neto JL, Moon S, Jang J, Yang G, Lee C, Moon HK, Chatelain E, Genovesio A, Cechetto J (2012) An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages. PLoS Negl Trop Dis 6(6):e1671. https:\/\/doi.org\/10.1371\/journal.pntd.0001671","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"6493_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064693","volume":"8","author":"RY Gaji","year":"2013","unstructured":"Gaji RY, Huynh MH, Carruthers VB (2013) A novel high throughput invasion screen identifies host actin regulators required for efficient cell entry by Toxoplasma gondii. PLoS One 8(5):e64693. https:\/\/doi.org\/10.1371\/journal.pone.0064693","journal-title":"PLoS One"},{"key":"6493_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2165\/00003495-199448020-00005","volume":"48","author":"VS Georgiev","year":"1994","unstructured":"Georgiev VS (1994) Management of toxoplasmosis. Drugs 48:179\u2013188. https:\/\/doi.org\/10.2165\/00003495-199448020-00005","journal-title":"Drugs"},{"key":"6493_CR32","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/AAC.47.1.309-316.2003","volume":"47","author":"MJ Gubbels","year":"2003","unstructured":"Gubbels MJ, Li C, Striepen B (2003) High-throughput growth assay for Toxoplasma gondii using yellow fluorescent protein. Antimicrob Agents Chemother 47:309\u2013316. https:\/\/doi.org\/10.1128\/AAC.47.1.309-316.2003","journal-title":"Antimicrob Agents Chemother"},{"key":"6493_CR33","doi-asserted-by":"publisher","first-page":"15913","DOI":"10.1074\/jbc.M108393200","volume":"277","author":"AM Gurnett","year":"2002","unstructured":"Gurnett AM, Liberator PA, Dulski PM, Salowe SP, Donald RG, Anderson JW, Wiltsie J, Diaz CA, Harris G, Chang B, Darkin-Rattray SJ, Nare B, Crumley T, Blum PS, Misura AS, Tamas T, Sardana MK, Yuan J, Biftu T, Schmatz DM (2002) Purification and molecular characterization of cGMP-dependent protein kinase from Apicomplexan parasites. A novel chemotherapeutic target. J Biol Chem 277:15913\u201315922. https:\/\/doi.org\/10.1074\/jbc.M108393200","journal-title":"J Biol Chem"},{"key":"6493_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.mib.2015.04.003","volume":"26","author":"MA Hakimi","year":"2015","unstructured":"Hakimi MA, Bougdour A (2015) Toxoplasma\u2019s ways of manipulating the host transcriptome via secreted effectors. Curr Opin Microbiol 26:24\u201331. https:\/\/doi.org\/10.1016\/j.mib.2015.04.003","journal-title":"Curr Opin Microbiol"},{"key":"6493_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/B978-0-444-53490-3.00008-X","volume":"114","author":"SK Halonen","year":"2013","unstructured":"Halonen SK, Weiss LM (2013) Toxoplasmosis. Handb Clin Neurol 114:125\u2013145. https:\/\/doi.org\/10.1016\/B978-0-444-53490-3.00008-X","journal-title":"Handb Clin Neurol"},{"key":"6493_CR36","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/0002-9343(87)90151-3","volume":"82","author":"HW Haverkos","year":"1987","unstructured":"Haverkos HW (1987) Assessment of therapy for toxoplasma encephalitis. The TE Study Group. Am J Med 82:907\u2013914. https:\/\/doi.org\/10.1016\/0002-9343(87)90151-3","journal-title":"Am J Med"},{"issue":"1","key":"6493_CR37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1079\/AHR2005100","volume":"6","author":"DE Hill","year":"2005","unstructured":"Hill DE, Chirukandoth S, Dubey JP (2005) Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 6(1):41\u201361. https:\/\/doi.org\/10.1079\/AHR2005100","journal-title":"Anim Health Res Rev"},{"key":"6493_CR38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1006\/expr.1994.1024","volume":"78","author":"DK Howe","year":"1994","unstructured":"Howe DK, Sibley LD (1994) Toxoplasma gondii: analysis of different laboratory stocks of the RH strain reveals genetic heterogeneity. Exp Parasitol 78:242\u2013245. https:\/\/doi.org\/10.1006\/expr.1994.1024","journal-title":"Exp Parasitol"},{"key":"6493_CR39","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","volume":"172","author":"DK Howe","year":"1995","unstructured":"Howe DK, Sibley DL (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172:1561\u20131566. https:\/\/doi.org\/10.1093\/infdis\/172.6.1561","journal-title":"J Infect Dis"},{"issue":"5","key":"6493_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1097\/00002030-200103300-00007","volume":"15","author":"JM Jacobson","year":"2001","unstructured":"Jacobson JM, Hafner R, Remington J et al (2001) Dose-escalation, phase I\/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS. AIDS 15(5):583\u2013589. https:\/\/doi.org\/10.1097\/00002030-200103300-00007","journal-title":"AIDS"},{"issue":"2","key":"6493_CR41","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/clinids\/22.2.268","volume":"22","author":"C Katlama","year":"1996","unstructured":"Katlama C, De Wit S, O\u2019Doherty E, Van Glabeke M, Clumeck N (1996) Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS. Clin Infect Dis 22(2):268\u2013275. https:\/\/doi.org\/10.1093\/clinids\/22.2.268","journal-title":"Clin Infect Dis"},{"key":"6493_CR42","doi-asserted-by":"publisher","first-page":"11423","DOI":"10.1073\/pnas.0601438103","volume":"103","author":"T Lehmann","year":"2006","unstructured":"Lehmann T, Marcet PL, Graham DH, Dahl ER, Dubey JP (2006) Globalization and the population structure of Toxoplasma gondii. Proc Natl Acad Sci U S A 103:11423\u201311428. https:\/\/doi.org\/10.1073\/pnas.0601438103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6493_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/0002-9343(88)90014-9","volume":"84","author":"C Leport","year":"1988","unstructured":"Leport C, Raffi F, Matheron S, Katlama C, Regnier B, Saimot AG, Marche C, Vedrenne C, Vilde JL (1988) Treatment of central nervous system toxoplasmosis with pyrimethamine\/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. Am J Med 84:94\u2013100. https:\/\/doi.org\/10.1016\/0002-9343(88)90014-9","journal-title":"Am J Med"},{"key":"6493_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1550-7408.1980.tb04228.x","volume":"27","author":"ND Levine","year":"1980","unstructured":"Levine ND, Corliss JO, Cox FEG, Deroux G, Grain J, Honigberg BM, Leedale GF, Loeblich AR, Lom J, Lynn D, Merinfeld EG, Page FC, Poljansky G, Sprague V, Vavra J, Wallace FG (1980) A newly revised classification of the Protozoa. J Protozool 27:37\u201358. https:\/\/doi.org\/10.1111\/j.1550-7408.1980.tb04228.x","journal-title":"J Protozool"},{"issue":"6","key":"6493_CR45","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1128\/EC.00381-08","volume":"8","author":"SS Lin","year":"2009","unstructured":"Lin SS, Gross U, Bohne W (2009) Type II NADH dehydrogenase inhibitor 1-hydroxy-2-dodecyl-4(1H)quinolone leads to collapse of mitochondrial inner-membrane potential and ATP depletion in Toxoplasma gondii. Eukaryot Cell 8(6):877\u2013887. https:\/\/doi.org\/10.1128\/EC.00381-08","journal-title":"Eukaryot Cell"},{"issue":"1","key":"6493_CR46","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2307\/3282569","volume":"77","author":"DS Lindsay","year":"1991","unstructured":"Lindsay DS, Dubey JP, Blagburn BL, Toivio-Kinnucan M (1991) Examination of tissue cyst formation by Toxoplasma gondii in cell cultures using bradyzoites, tachyzoites, and sporozoites. J Parasitol 77(1):126\u2013132. https:\/\/doi.org\/10.2307\/3282569","journal-title":"J Parasitol"},{"issue":"7","key":"6493_CR47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.15698\/mic2017.07.579","volume":"4","author":"CGK L\u00fcder","year":"2017","unstructured":"L\u00fcder CGK, Rahman T (2017) Impact of the host on Toxoplasma stage differentiation. Microb Cell 4(7):203\u2013211. https:\/\/doi.org\/10.15698\/mic2017.07.579","journal-title":"Microb Cell"},{"issue":"1","key":"6493_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1006\/expr.1999.4421","volume":"93","author":"Carsten G.K. L\u00fcder","year":"1999","unstructured":"L\u00fcder CGK, Giraldo-Vel\u00e1squez M, Sendtner M, Gross U (1999) Toxoplasma gondii in Primary Rat CNS Cells: Differential Contribution of Neurons, Astrocytes, and Microglial Cells for the Intracerebral Development and Stage Differentiation. Exp Parasitol 93(1):23-32. https:\/\/doi.org\/10.1006\/expr.1999.4421","journal-title":"Experimental Parasitology"},{"key":"6493_CR49","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1365-3024.1995.tb00902.x","volume":"17","author":"RE Lyons","year":"1995","unstructured":"Lyons RE, Johnson AM (1995) Heat shock proteins of Toxoplasma gondii. Parasite Immunol 17:353\u2013359. https:\/\/doi.org\/10.1111\/j.1365-3024.1995.tb00902.x","journal-title":"Parasite Immunol"},{"key":"6493_CR50","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1136\/jcp.2003.013763","volume":"57","author":"S Mavin","year":"2004","unstructured":"Mavin S, Joss AWL, Ball J, Ho-Yen DO (2004) Do Toxoplasma gondii RH strain tachyzoites evolve during continuous passage? J ClinPathol 57:609\u2013611. https:\/\/doi.org\/10.1136\/jcp.2003.013763","journal-title":"J ClinPathol"},{"key":"6493_CR51","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/clinids\/18.1.38","volume":"18","author":"J Mcauley","year":"1994","unstructured":"Mcauley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, Wolters C, Stein L, Stein M, Schey W, Remington J, Meier P, Johnson D, Heydeman P, Holfels E, Withers S, Mack D, Brown C, Patton D, McLeod R (1994) Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial. Clin Infect Dis 18:38\u201372. https:\/\/doi.org\/10.1093\/clinids\/18.1.38","journal-title":"Clin Infect Dis"},{"issue":"6","key":"6493_CR52","doi-asserted-by":"publisher","first-page":"29179","DOI":"10.1038\/srep29179","volume":"14","author":"M McPhillie","year":"2016","unstructured":"McPhillie M, Zhou Y, El Bissati K, Dubey J, Lorenzi H, Capper M, Lukens AK, Hickman M, Muench S, Verma SK, Weber CR, Wheeler K, Gordon J, Sanders J, Moulton H, Wang K, Kim TK, He Y, Santos T, Woods S, Lee P, Donkin D, Kim E, Fraczek L, Lykins J, Esaa F, Alibana-Clouser F, Dovgin S, Weiss L, Brasseur G, Wirth D, Kent M, Hood L, Meunieur B, Roberts CW, Hasnain SS, Antonyuk SV, Fishwick C, McLeod R (2016) New paradigms for understanding and step changes in treating active and chronic, persistent apicomplexan infections. Sci Rep 14(6):29179. https:\/\/doi.org\/10.1038\/srep29179","journal-title":"Sci Rep"},{"key":"6493_CR53","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1128\/AAC.01203-07","volume":"52","author":"P Meneceur","year":"2008","unstructured":"Meneceur P, Bouldouyre MA, Aubert D, Villena I, Menotti J, Sauvage V, Garin JF, Derouin F (2008) In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone. Antimicrob Agents Chemother 52:1269\u20131277. https:\/\/doi.org\/10.1128\/AAC.01203-07","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"6493_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/cyto.a.20202","volume":"69A","author":"J Mital","year":"2006","unstructured":"Mital J, Schwarz J, Taatjes DJ, Ward GE (2006) Laser scanning cytometer-based assays for measuring host cell attachment and invasion by the human pathogen Toxoplasma gondii. Cytometry Part A 69A(1):13\u201319. https:\/\/doi.org\/10.1002\/cyto.a.20202","journal-title":"Cytometry Part A"},{"issue":"10","key":"6493_CR55","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1007\/s00436-018-6027-z","volume":"117","author":"M Montazeri","year":"2018","unstructured":"Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Shahdin S, Daryani A (2018) Activities of anti-Toxoplasma drugs and compounds against tissue cysts in the last three decades (1987 to 2017), a systematic review. Parasitol Res 117(10):3045\u20133057. https:\/\/doi.org\/10.1007\/s00436-018-6027-z","journal-title":"Parasitol Res"},{"key":"6493_CR56","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O (2004) Toxoplasmosis. Lancet 363:1965\u20131976. https:\/\/doi.org\/10.1016\/S0140-6736(04)16412-X","journal-title":"Lancet"},{"key":"6493_CR57","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1128\/AAC.46.2.300-307.2002","volume":"46","author":"B Nare","year":"2002","unstructured":"Nare B, Allocco JJ, Liberator PA, Donald RG (2002) Evaluation of a cyclic GMP dependent protein kinase inhibitor in treatment of murine toxoplasmosis: gamma interferon is required for efficacy. Antimicrob Agents Chemother 46:300\u2013307. https:\/\/doi.org\/10.1128\/AAC.46.2.300-307.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"6493_CR58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.parint.2012.12.003","volume":"62","author":"TC Paredes-Santos","year":"2013","unstructured":"Paredes-Santos TC, Martins-Duarte ES, Vitor RWA, De Souza W, Attias M, Vommaro RC (2013) Spontaneous cystogenesis in vitro of a Brazilian strain of Toxoplasma gondii. Parasitol Int 62:181\u2013188. https:\/\/doi.org\/10.1016\/j.parint.2012.12.003","journal-title":"Parasitol Int"},{"key":"6493_CR59","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.micinf.2015.09.016","volume":"18","author":"TC Paredes-Santos","year":"2016","unstructured":"Paredes-Santos TC, Tomita T, Yan Fen M, De Souza W, Attias M, Vommaro RC, Weiss LM (2016) Development of dual fluorescent stage specific reporter strain of Toxoplasma gondii to follow tachyzoites and bradyzoite development in vitro and in vivo. Microbes Infect 18:39\u201347. https:\/\/doi.org\/10.1016\/j.micinf.2015.09.016","journal-title":"Microbes Infect"},{"key":"6493_CR60","doi-asserted-by":"publisher","first-page":"7374","DOI":"10.1128\/AAC.00057-15","volume":"59","author":"JDA Portes","year":"2015","unstructured":"Portes JDA, De Souza TG, Santos TAT, Da Silva LLR, Ribeiro TP, Pereira MD, Junior AH, Fernandes C, Damatta RA, De Souza W, Seabra SH (2015) Reduction of Toxoplasma gondii development due to inhibition of parasite antioxidant enzymes by a dinuclear iron(III) compound. Antimicrob Agents Chemother 59:7374\u20137386. https:\/\/doi.org\/10.1128\/AAC.00057-15","journal-title":"Antimicrob Agents Chemother"},{"key":"6493_CR61","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1177\/1533317513517049","volume":"29","author":"J Prandota","year":"2014","unstructured":"Prandota J (2014) Possible link between Toxoplasma gondii and the anosmia associated with neurodegenerative diseases. Am J Alzheimers Dis Other Dement 29:205\u2013214. https:\/\/doi.org\/10.1177\/1533317513517049","journal-title":"Am J Alzheimers Dis Other Dement"},{"issue":"6","key":"6493_CR62","doi-asserted-by":"publisher","first-page":"e16712012","DOI":"10.1371\/journal.pntd.0001671","volume":"6","author":"JL Siqueira-Neto","year":"2012","unstructured":"Siqueira-Neto JL, Moon S, Jang J, Yang G, Lee C, Moon HK, Chatelain E, Genovesio A, Cechetto J, Freitas-Junior LH (2012) An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages. PLoS Negl Trop Dis 6(6):e16712012. https:\/\/doi.org\/10.1371\/journal.pntd.0001671","journal-title":"PLoS Negl Trop Dis"},{"key":"6493_CR63","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/978-3-642-51014-4_8","volume":"219","author":"M Soete","year":"1996","unstructured":"Soete M, Dubremetz JF (1996) Toxoplasma gondii: kinetics of stage-specific protein expression during tachyzoite-bradyzoite conversion in vitro. Curr Top Microbiol Immunol 219:76\u201380. https:\/\/doi.org\/10.1007\/978-3-642-51014-4_8","journal-title":"Curr Top Microbiol Immunol"},{"key":"6493_CR64","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1006\/expr.1994.1039","volume":"78","author":"M Soete","year":"1994","unstructured":"Soete M, Camus D, Dubremetz JF (1994) Experimental induction of bradyzoite-specific antigen expression and cyst formation by the RH strain of Toxoplasma gondii in vitro. Exp Parasitol 78:361\u2013370","journal-title":"Exp Parasitol"},{"issue":"6","key":"6493_CR65","doi-asserted-by":"publisher","first-page":"e62906","DOI":"10.1371\/journal.pone.0062906","volume":"8","author":"T Spangenberg","year":"2013","unstructured":"Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TNC, Willis P (2013) The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS One 8(6):e62906. https:\/\/doi.org\/10.1371\/journal.pone.0062906","journal-title":"PLoS One"},{"key":"6493_CR66","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S0031182097001959","volume":"116","author":"CA Speer","year":"1998","unstructured":"Speer CA, Dubey JP (1998) Ultrastructure of early stages of infections in mice fed Toxoplasma gondii oocysts. Parasitol 116:35\u201342. https:\/\/doi.org\/10.1017\/S0031182097001959","journal-title":"Parasitol"},{"key":"6493_CR67","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1590\/S0074-02762009000200005","volume":"104","author":"WJ Sullivan Jr","year":"2009","unstructured":"Sullivan WJ Jr, Smith AT, Joyce BR (2009) Understanding mechanisms and the role of differentiation in pathogenesis of Toxoplasma gondii\u2014a review. Mem Inst Oswaldo Cruz 104:155\u2013161. https:\/\/doi.org\/10.1590\/S0074-02762009000200005","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"6493_CR68","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/clinids\/24.3.422","volume":"24","author":"RA Torres","year":"1997","unstructured":"Torres RA, Weinberg W, Stansell J, Leoung G, Kovacs J, Rogers M, Scott J (1997) Atovaquone for salvage treatment and suppression of toxoplasmic encephalitis in patients with AIDS. Atovaquone\/Toxoplasmic Encephalitis Study Group. Clin Infect Dis 24(3):422\u2013429. https:\/\/doi.org\/10.1093\/clinids\/24.3.422","journal-title":"Clin Infect Dis"},{"key":"6493_CR69","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/j.ophtha.2009.04.042","volume":"116","author":"DV Vasconcelos-Santos","year":"2009","unstructured":"Vasconcelos-Santos DV, Machado DO, Campos WR, Or\u00e9fice F, Andrade GMQ, Carellos EVM, Romanelli RM, Januario JN, Resende LM, Martins-Filho O, Carneiro ACAV, Vitor RWA, Caiaffa WT (2009) Congenital toxoplasmosis in southeastern Brazil: results of early ophthalmologic examination of a large cohort of neonates. Ophthalmology 116:2199\u20132205. https:\/\/doi.org\/10.1016\/j.ophtha.2009.04.042","journal-title":"Ophthalmology"},{"issue":"1","key":"6493_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1590\/S0037-86822002000100001","volume":"35","author":"PVT Vidigal","year":"2002","unstructured":"Vidigal PVT, Santos DVV, Castro FC, Couto JCF, Vitor RWA, Filho GB (2002) Pre-natal toxoplasmosis diagnosis from amniotic fluid by PCR. Diagn\u00f3stico pr\u00e9-natal da toxoplasmose no l\u00edquido amni\u00f3tico atrav\u00e9s da t\u00e9cnica de PCR. Rev Soc Bras Med Trop 35(1):1\u20136. https:\/\/doi.org\/10.1590\/S0037-86822002000100001","journal-title":"Rev Soc Bras Med Trop"},{"key":"6493_CR71","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/S0020-7519(97)00144-6","volume":"27","author":"O Villard","year":"1997","unstructured":"Villard O, Candolfi E, Ferguson DJP, Marcellin L, Kien T (1997) Loss of oral infectivity of tissue cysts of Toxoplasma gondii RH strain to outbred Swiss-Webster mice. Int J Parasitol 27:1555\u20131559. https:\/\/doi.org\/10.1016\/S0020-7519(97)00144-6","journal-title":"Int J Parasitol"},{"key":"6493_CR72","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1550-7408.1995.tb01556.x","volume":"42","author":"LM Weiss","year":"1995","unstructured":"Weiss LM, Laplace D, Takvorian PM, Tanowitz HB, Cali A, Wittner M (1995) A cell culture system for study of the development of Toxoplasma gondii bradyzoites. J Eukaryot Microbiol 42:150\u2013157. https:\/\/doi.org\/10.1111\/j.1550-7408.1995.tb01556.x","journal-title":"J Eukaryot Microbiol"},{"key":"6493_CR73","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s00417-010-1379-9","volume":"248","author":"S Winterhalter","year":"2010","unstructured":"Winterhalter S, Severing K, Stammen J, Maier AK, Godehardt E, Joussen AM (2010) Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis? Graefes Arch Clin Exp Ophthalmol 248:1187\u20131192. https:\/\/doi.org\/10.1007\/s00417-010-1379-9","journal-title":"Graefes Arch Clin Exp Ophthalmol"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-019-06493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00436-019-06493-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-019-06493-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:18:24Z","timestamp":1605226704000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00436-019-06493-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,14]]},"references-count":73,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6493"],"URL":"https:\/\/doi.org\/10.1007\/s00436-019-06493-6","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,14]]},"assertion":[{"value":"28 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}